About: Recommendations on Management of Locally Advanced Rectal Cancer During the COVID-19 Pandemic: an Iranian Consensus

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Recommendations on Management of Locally Advanced Rectal Cancer During the COVID-19 Pandemic: an Iranian Consensus Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Recommendations on Management of Locally Advanced Rectal Cancer During the COVID-19 Pandemic: an Iranian Consensus
Creator	Rakhsha, Afshin Taghizadeh-Hesary, Farzad Siavashpour, Zahra
topic	covid:ad51bb2eff7a9579f64942f1621defeb40a08f1e#this
Source	Medline; PMC
abstract	PURPOSE: Today, the rapid outbreak of COVID-19 is the leading health issue. Patients with cancer are at high risk for the development of morbidities of COVID-19. Hence, oncology centers need to provide organ-based recommendations for optimal management of cancer in the COVID-19 era. METHODS: In this article, we have provided the recommendations on management of locally advanced rectal cancer during the COVID-19 pandemic based on our experience in Shohada-e Tajrish Hospital, Iran. RESULTS: We recommend that patients with locally advanced rectal cancer should be managed in an individualized manner in combination with local conditions related to COVID-19. CONCLUSION: Our recommendation may provide a guide for oncology centers of developing countries for better management of locally advanced rectal cancer.
has issue date	2020-07-13(xsd:dateTime)
bibo:doi	10.1007/s12029-020-00454-4
bibo:pmid	32656628
has license	no-cc
sha1sum (hex)	ad51bb2eff7a9579f64942f1621defeb40a08f1e
schema:url	https://doi.org/10.1007/s12029-020-00454-4
resource representing a document's title	Recommendations on Management of Locally Advanced Rectal Cancer During the COVID-19 Pandemic: an Iranian Consensus
has PubMed Central identifier	PMC7355082
has PubMed identifier	32656628
schema:publication	J Gastrointest Cancer
resource representing a document's body	covid:ad51bb2eff7a9579f64942f1621defeb40a08f1e#body_text
is http://vocab.deri.ie/void#inDataset of	proxy:http/ns.inria.fr/covid19/ad51bb2eff7a9579f64942f1621defeb40a08f1e
is schema:about of	named entity 'cancer' named entity 'management' named entity 'era' named entity 'INDIVIDUALIZED' named entity 'optimal' named entity 'cancer' named entity 'locally' named entity 'Results' named entity 'management' named entity 'provide' named entity 'Patients' named entity 'COVID-19' named entity 'COVID-19' named entity 'management of cancer' named entity 'Rectal Cancer' named entity 'Locally Advanced' named entity 'COVID-19 Pandemic' named entity 'micrometastasis' named entity 'elective surgeries' named entity 'EBRT' named entity 'comorbidities' named entity 'COVID-19 outbreak' named entity 'watch and wait' named entity 'tumors' named entity 'chemotherapy' named entity 'capecitabine' named entity 'chemotherapy' named entity 'FOLFOX' named entity 'tumors' named entity 'IORT' named entity 'perforation' named entity 'Clinical Oncology' named entity 'intravenous' named entity 'morbidity' named entity 'oxaliplatin' named entity 'COVID-19' named entity 'COVID-19 pandemic' named entity 'chemotherapy' named entity 'COVID-19 pandemic' named entity 'outpatient setting' named entity 'induction chemotherapy' named entity 'carbon dioxide' named entity 'tumor' named entity 'aerosolization' named entity '5-FU' named entity 'complete response' named entity 'March 2020' named entity 'gastrointestinal bleeding' named entity 'chemotherapy' named entity 'massive bleeding' named entity 'capecitabine' named entity 'adjuvant chemotherapy' named entity 'pCR' named entity 'infection' named entity 'AJCC' named entity 'COVID-19 pandemic' named entity 'endoscopic' named entity 'rectal cancer' named entity 'peritonitis' named entity 'COVID-19 outbreak' named entity 'toxicity' named entity 'palliation' named entity 'cost-effectiveness' named entity '19, 20' named entity 'distal' named entity 'brachytherapy' named entity 'COVID-19' named entity 'viscus' named entity 'surgical complications' named entity 'Asian' named entity 'neoadjuvant' named entity 'life-threatening' named entity 'CAPOX' named entity 'resection' named entity 'probability' named entity 'IORT' named entity 'hematologic'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software